In the following, different genetic variants of several genes, e.g., glutathione S-transferase genes, interleukin (IL) genes or variants at chromosome 17, are described which may lead to increased adverse health effects (e.g., asthma, wheezing, sudden infant death syndrome, congenital heart defects). The gene discussed is HPGDS; the disease is asthma.